Thrombolytic Science
Get Full AccessDescription
- TSI is a privately-held vascular medicine and biotechnology company currently developing a new-generation clot-dissolving therapy with the first novel mechanism of action in 20 years for stroke and other thrombotic diseases. TSIs technology is based upon pioneering earlier work on pro-urokinase (proUK) by its cofounders. The primary component of TSIs thrombolytic therapy is a rationally designed mutant of proUK.
-
Headquarters:763d Concord Avenue , Cambridge, Massachusetts, United States
More -
Phone Number: +1 617-230-7439
-
Website: https://www.tsillc.net
-
Employees:3
-
Revenue:$1 - 10M
-
Legal Name:Thrombolytic Science
-
Thrombolytic Science's Social Media
-
Is this data correct?
-
| NAICS Code: 541720 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
View Employees
Frequently Asked Questions regarding Thrombolytic Science
-
Where are Thrombolytic Science's Headquarters?
Thrombolytic Science's Headquarters are in 763d Concord Avenue ,Cambridge,Massachusetts,United States
-
What is Thrombolytic Science's phone number?
Thrombolytic Science's phone number is +1 617-230-7439
-
What is Thrombolytic Science's official website?
Thrombolytic Science's official website is https://www.tsillc.net
-
What is Thrombolytic Science's Revenue?
Thrombolytic Science's revenue is $1 - 10M
-
What is Thrombolytic Science's NAICS code?
Thrombolytic Science's NAICS code is 541720
-
How many employees are working in Thrombolytic Science
Thrombolytic Science has 3 employees
-
What is Thrombolytic Science's Industry?
Thrombolytic Science is in the industry of Biotechnology
-
Who is Thrombolytic Science's CEO?
Thrombolytic Science's CEO is Alexis Wallace